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In Brief
Herpes simplex virus 1 is a ubiquitous
human pathogen and the cause of several
ailments. Enk et al. found that the HSV1-
encoded miR H8 targets the GPI
anchoring pathway, reducing expression
of several immune-modulating proteins,
thus enhancing viral spread and enabling
evasion of natural killer cell elimination.
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Herpes simplex virus 1 (HSV1) is a ubiquitous human
pathogen that utilizes variable mechanisms to evade
immune surveillance. The glycosylphosphatidylino-
sitol (GPI) anchoring pathway is a multistep process
in which a myriad of different proteins are covalently
attached to a GPI moiety to be presented on the cell
surface. Among the different GPI-anchored proteins
there are many with immunological importance. We
present evidence that the HSV1-encoded miR H8
directly targets PIGT, a member of the protein
complex that covalently attaches proteins to GPI in
the final step of GPI anchoring. This results in a
membrane down-modulation of several different
immune-related, GPI-anchored proteins, including li-
gands for natural killer-activating receptors and the
prominent viral restriction factor tetherin. Thus, we
suggest that by utilizing just one of dozens of
miRNAs encoded by HSV1, the virus can counteract
the host immune response at several key points.INTRODUCTION
Herpes simplex virus 1 (HSV1) is an a-herpesvirus and the
etiological cause of several diseases. HSV1 establishes a life-
long latent infection in the sensory nerve ganglia of the nerves
innervating the primary site of infection (Arvin et al., 2007).
Humans and HSV1 have co-evolved for millennia. The host im-
mune response toward HSV1 entails both adaptive responses
and innate responses, which includes both cell-intrinsic and
cell-extrinsic responses (Arvin et al., 2007). The cell-intrinsic
response involves cell-autonomous sensing of viral infection
and subsequent production of type I interferons that induce
interferon-stimulated genes, including the potent antiviral protein
tetherin (Levy et al., 2011). Tetherin acts as a tether of budding
viruses, adhering them to the infected cell surface and limitingCell
This is an open access article under the CC BY-Nviral spread (Neil, 2013). The cell-extrinsic innate immune
response involves recruitment of cellular immune responders,
including natural killer (NK) cells.
NK cells are innate lymphocytes that kill tumor and virally in-
fected cells (Vivier et al., 2011) and are considered members of
the innate lymphoid cell (ILC) family, classified under the ILC1
family (Artis and Spits, 2015). The NK response to target cells is
dictated by a balance of signals delivered from activating and
inhibitory receptors. The inhibitory NK cell receptors recognize
mainly major histocompatibility complex (MHC) class I proteins
(Koch et al., 2013), whereas the activating receptors recognize tu-
mor-, pathogen-, and stress-induced ligands and self-ligands
(Long et al., 2013). A principal activating NK receptor is NKG2D,
which recognizes several stress-induced ligands: MHC class I
polypeptide-related sequence A and B (MICA and MICB) and the
UL16 binding protein 1-6 (ULBP1-6) (Lanier, 2015), variably ex-
pressed by tumor cells and upregulated by cellular stresses, like
those that occur during viral infections (Iannello and Raulet,
2013). Additionally, NK cells express several other activating re-
ceptors, such as 2B4, which recognizes CD48, a cognate ligand/
receptor expressed by other immune cells (Kim et al., 2014b).
Other activating NK receptors, such as the natural cytotoxicity
receptors (NCRs) NKp30, NKp44, and NKp46, bind mostly viral
hemagglutinins and unknown cellular ligands (Koch et al., 2013).
MicroRNAs (miRNAs or miRs) are short non-coding RNAs that
bind target mRNAs and repress their translation (Guo et al.,
2010). Generally, the effect of miRNAs on target protein expres-
sion is relatively mild (Baek et al., 2008). Notably, viruses, espe-
cially of the herpesvirus family, encode for miRNAs that can
modulate host gene expression (Skalsky and Cullen, 2010).
Indeed, we have previously demonstrated viral miRNA-based
immune-evasive mechanisms (Stern-Ginossar et al., 2007;
Nachmani et al., 2010, Nachmani et al., 2009; Bauman et al.,
2011). HSV1 encodes 27 known miRNAs that are variably ex-
pressed during the viral lifecycle (Cui et al., 2006; Umbach
et al., 2009; Kozomara and Griffiths-Jones; 2014; Du et al.,
2015). The functions of the HSV1 miRNAs are largely unknown,
and it is unknown whether they affect the counter-HSV1 immune
response.Reports 17, 949–956, October 18, 2016 ª 2016 The Author(s). 949
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Most cell surface proteins are membrane-integral; however,
some are covalently attached to glycosylphosphatidylinositol
(GPI) lipid anchors. The GPI anchoring pathway is a multistep
process that involves more than 25 proteins and in which the
GPI-transamidase (GPIT) complex covalently attaches the sub-
strate pro-protein C terminus to the GPI moiety (Kinoshita,
2014). GPIT consists of five known proteins: PIGK, PIGS,
PIGT, PIGU, and GPAA1, of which PIGK is widely accepted
as the catalytic subunit (Kinoshita, 2014). Importantly, PIGT
and PIGK share a disulfide bond, and PIGT is thought to be
involved in GPIT complex stabilization (Kinoshita, 2014).
Additionally, according to the predicted 3D model, PIGT forms
a b-propeller gate that regulates access into the catalytic site of
GPIT (Eisenhaber et al., 2003). Here we demonstrate that HSV1
miR H8 targets PIGT to avoid NK cell attack and the effects of
tetherin.
RESULTS
HSV1miR H8 Downmodulates the Expression of Several
Activating NK Ligands
Previously, we described viral miRNA-based mechanisms
utilized by herpesviruses to downregulate the expression of
MICB, an NKG2D ligand, to evade NK cell recognition and
elimination (Stern-Ginossar et al., 2007; Nachmani et al.,
2009, 2010). Here we investigated whether some of the 27
HSV1-encoded miRNAs might target NKG2D ligands. For
this, we transduced the B cell line BJAB, which endogenously
expresses five NKG2D ligands—MICA, MICB, and ULBP1–3—
as well as many other known and unknown activating NK re-
ceptor ligands with lentiviral vectors encoding for artificial
hairpins that are processed into mature HSV1 miRNAs, as
described previously (Stern-Ginossar et al., 2007). We found
that 19 of the HSV1-encoded miRNAs tested had no effect
on the expression of the NKG2D stress-induced ligands (Fig-
ure S1). However, miR H8 did significantly reduce the expres-
sion level of two NKG2D ligands, ULBP2 and ULBP3, and the
expression of the 2B4 ligand CD48 (Figure 1A, quantified in
Figure 1B). Notably, the miR H8 effect was very pronounced
(Figure 1A), unlike the expected effects (Baek et al., 2008;
Bauman et al., 2011; Stern-Ginossar et al., 2007; Nachmani
et al., 2009, 2010). We verified expression of miR H8 in the
transduced cells (Figure 1C).
Several other activating NK receptors, including the NCRs
NKp44 and NKp46, and the short-tailed killer-cell immunoglob-
ulin-like receptors (KIRs) bind to yet unknown ligands. To inves-
tigate whether miR H8 might affect the expression of these
ligands, we utilized fusion proteins consisting of the extracellular
portions of the different activating NK receptors fused to the Fc
portion of the human immunoglobulin 1 (IgG1). Expression of
miR H8 did not affect the expression of any of these unknown
activating NK cell ligands (Figure 1D).
We also transduced BJAB cells with the full-length precursor
miR of H8 (pre-H8). Using this modality, we utilized the cellular
components that normally process precursor miRNAs into
mature miRNAs. The results obtained using pre-H8 were practi-
cally identical to the results obtained using the miR H8 from the
artificial hairpin (Figure 1E).950 Cell Reports 17, 949–956, October 18, 2016HSV1 miR H8 Targets PIGT of the GPI Anchoring
Pathway
Next we sought to identify the direct target(s) of miR H8. For this,
we utilized the RNA hybridization prediction program RNA-
hybrid (Rehmsmeier et al., 2004). Initially we examined the
transcripts of ULBP2, ULBP3, and CD48 for a binding site for
miR H8, but no such binding sites were predicted (data not
shown). Next, because ULBP2, ULBP3, and CD48 are all GPI-
anchored proteins, we examined the transcripts of the proteins
involved in GPI anchoring for predicted binding by miR H8.
One of these, PIGT of the GPIT complex, had a predicted binding
site for miR H8 (Figure 1F, top). This site was in the 30 UTR of
PIGT; it displayed full seed (bases 2–7 of the miR) complemen-
tarity and had additional supplemental binding sites in themiR 30.
To validate this bioinformatic prediction, we utilized a dual-
luciferase assay, as described previously (Nachmani et al.,
2010). As can be seen in Figure 1G, when the 30 UTR of PIGT
was expressed downstream of the luciferase, normalized
luciferase activity was dramatically reduced in the presence of
miR H8. However, mutating 2 base pairs (bp) in the seed binding
site for miR H8 (Figure 1F) reversed most of the miR H8 effect
(Figure 1G). Thus, miR H8 indeed targets the 30 UTR of PIGT at
the predicted binding site.
Next, to ensure that endogenous PIGT is targeted by miR H8,
we stained BJAB cells expressing miR H8 or a control miR with
an anti-PIGT antibody and quantified PIGT expression using
fluorescence-activated cell sorting (FACS) analysis. As can be
seen in Figure 2A, quantified in Figure 2B, PIGT levels were
reduced 40% in miR H8-expressing cells. PIGT mRNA levels
remained unchanged (Figure 2C), suggesting that miR H8 in-
duces translational inhibition. To validate that the effect of miR
H8 on the expression of the activating NK ligands is indeed
PIGT-dependent, we targeted PIGT directly using short hairpin
RNA (shRNA). PIGT expression was reduced, as assessed by
FACS staining (Figure 2D, quantified in Figure 2E) and by
qRT-PCR (Figure 2F). Moreover, the expression of ULBP2,
ULBP3, and CD48 was reduced to levels similar to the effect
elicited of miR H8 (Figure 2G).
HSV1 miR H8 Reduces NK-Dependent Killing
The functionality of the reductions observed in the levels of
ULBP2, ULBP3, and CD48 was tested using NK cytotoxicity as-
says. First we co-incubated our miR H8 and control cells with the
NK cell line YTS-ECO, known to kill target cells exclusively via
2B4-CD48 interactions (Chuang et al., 2000). Cells expressing
miR H8 were killed significantly less than control miRNA-ex-
pressing cells (Figure 3A). Moreover, when miR H8 and control
cells were incubated with primary bulk NK cells, the same effect
was observed. This reduction in NK cell killing was also seen
when the target cells expressed shPIGT but not shScramble
(Figure 3B). Furthermore, when miR H8-expressing cells were
rescued using exogenous PIGT, the miR H8 effect was reversed
(Figure 3C).
HSV1 miR H8-Mediated Reduction in PIGT Affect
Tetherin Expression
Next we tested whether miR H8’s effect on PIGTmight affect the
expression of the GPI anchored protein tetherin (also known as
Figure 1. HSV1miRH8 Reduces NKG2D and
2B4 Ligand Expression
(A) MiR H8-expressing BJAB cells were stained for
the indicated ligands. In all histograms, the black
histograms represent the staining of miR H8/or the
precursor miR H8, the empty gray histograms
represent staining of control SINGFP-expressing
cells, and the full gray histograms represent
staining of the SINGFP cells with secondary
antibody only. The background staining of cells
expressing miR H8/pre-miR H8 was similar to that
of SINGFP and is not shown.
(B) The fold change in mean fluorescent intensity
(MFI) compared with control miRNA-expressing
cells was calculated and analyzed using a single
sample t test. ULBBP2, n = 5; ULBP3, n = 6; CD48,
n = 6. Error bars represent SEM. ***p > 0.005.
(C) qRT-PCR for the expression of miR H8.
Mean values and SEM error bars are derived from
quadruplicates.
(D) BJAB-miR H8/control vector cells were stained
with the indicated fusion proteins.
(E) FACS staining of ULBP2, ULBP3, and CD48 in
cells expressing pre-miR H8. Staining for all figure
parts was repeated at least three times.
(F) Sequence and predicted hybridization of HSV1
miR H8 with its target in the PIGT 30 UTR (204–230
refers to the base number in the PIGT 30 UTR). The
miR H8 seed region is underlined (top). Shown is
sequence alignment of miR H8 and the mutated 30
UTR of PIGT (bottom).
(G) Relative luciferase activity is displayed for miR
H8-expressing HeLa cells (compared with cells
expressing a control HSV1 miR H15) transiently
transfected with a luciferase reporter attached to a
control 30 UTR, the 30 UTR of PIGT, or a mutated 30
UTR of PIGT with a two-base substitution in the
seed binding region of miR H8 (as depicted in F).
Shown are mean values and SEM, and error bars
were derived from triplicates. The figure shows a
representative experiment of four performed.
***p > 0.005. See also Figure S1 and S2 and Tables
S1 and S2.BST2/CD317). For this, we stained our HSV1 miR H8- and con-
trol miRNA-expressing cells with an anti-tetherin antibody and
observed that expression of miR H8 significantly reduced the
expression levels of tetherin (Figure 4A; quantified in Figure 4B).
Importantly, pre-H8 caused the same marked reduction in
tetherin expression (Figure 4C), as did shPIGT (Figure 4D).
Next, to examine the functionality of the decrease in tetherin
expression, we infected miR H8- and control empty vector-ex-
pressing cells with HSV1-RFP. 72 hr after infection, the superna-
tants were used to titrate the viral load in Vero cells. As expected,
miR H8-expressing cells with low tetherin expression were
significantly more susceptible to HSV1 infection and produced
more viral progeny than control vector-expressing cells. Indeed,
shPIGT elicited the same effect and so did shTetherin, but to aCell Rstronger degree (Figure 4E). Additionally,
reconstitution of PIGT in miR H8-express-
ing cells (H8-PIGT) reversed this effect
compared with miR H8-expressing cellstransfected with an empty vector (H8-ds) (Figure 4F). In this
setting, the cells expressing shTetherin were also the cells that
displayed the highest release of virus, and the controls, express-
ing a control miR with the empty vector (Control miR-ds) and an
shScramble, displayed the lowest viral release. When relative
viral release was measured (explained in Experimental Proced-
ures), cells expressing miR H8 showed a higher proportion of
viral release, as did the shTetherin- and shPIGT-expressing cells
compared with their appropriate controls (Figure 4G). Finally, to
validate that the miR H8 effect on HSV1 spread is mediated via
PIGT and tetherin, we expressed tetherin exogenously in A549
cells and transduced these cells with miR H8. As can be seen
in Figure 4H, miR H8 also enhanced viral release in this setting.
Thus, the effect of HSV1 miR H8 on PIGT expression and theeports 17, 949–956, October 18, 2016 951
Figure 2. HSV1 miR H8 Reduces the Protein
Levels of PIGT
(A) Intracellular FACS staining for PIGT. Black his-
tograms represent staining of miR H8-expressing
cells, empty gray histograms represent staining of
cells expressing a control miRNA, and the full gray
histograms represent staining of the control
miRNA with secondary antibody only. Isotype
control staining and background staining of miR
H8-expressing cells was similar to the control miR
staining and is not shown.
(B) Fold change in MFI compared with control
miRNA-expressing cells was calculate and
analyzed using a single sample t test (n = 5). Error
bars represent SEM.
(C) qRT-PCR for the expression of PIGT was con-
ducted on RNA samples from control miRNA- and
miR H8-expressing cells. Mean values and SEM
error bars are derived from quadruplicates.
(D) Intracellular FACS staining for PIGT in cells
expressing shRNA directed against PIGT (black) or
a scramble shRNA (shSCR, gray). Full gray histo-
grams represent staining of the shSCR cells with
secondary antibody only. Staining was repeated
five times.
(E) Fold change in MFI calculated for several ex-
periments as in (D) (n = 5). Error bars represent
SEM.
(F) qRT-PCR for the expression of PIGT in shPIGT-
and sh-SCR-expressing cells as in (C).
(G) Cells expressing shPIGT and shSCR stained for
the expression of the activating NK ligands dis-
played. Black histograms represent staining of
shPIGT-expressing cells, empty gray histograms
represent staining of cells expressing shSCR, and
the full gray histograms represent staining of
shSCR with secondary antibody only. The back-
ground staining of shPIGT-expressing cells was
similar to the shSCR staining and is not shown (for
D and G).
All experiments were performed at least three
times. *p > 0.05. See also Figure S1 and Table S1.downstream effects on GPI-anchored proteins facilitate viral
immune evasion at several different checkpoints.
DISCUSSION
Here we demonstrate that miR H8 significantly reduces the
membrane expression of the NKG2D ligands ULBP2 and
ULBP3 as well as the levels of CD48, a ligand for 2B4. We
demonstrate that miR H8 targets the 30 UTR of PIGT of the
GPIT complex seed dependently. Next we show that these
effects are biologically significant and reduce NK cell killing of
miR H8-expressing cells. Finally, we show that the dominant
cell-intrinsic antiviral protein tetherin, which is GPI-anchored, is
also affected by miR H8 expression. Tetherin is a cell-intrinsic,
interferon-inducible viral restriction factor (Neil, 2013). The
importance of tetherin in the anti-HSV1 response is emphasized
by the viral countermeasures employed to subvert its activity.
Two recent papers found that HSV1 counteracts tetherin via its952 Cell Reports 17, 949–956, October 18, 2016viral host shutoff gene as well as by its glycoprotein M (Blondeau
et al., 2013; Zenner et al., 2013). However, the effect of miR H8
via PIGT on tetherin levels was prominent enough to be of
biological significance in titration experiments even when these
mechanisms were at play.
Interestingly, the effect of miR H8 on PIGT levels and GPI
anchoring did not encompass all GPI-anchored proteins.
Namely, ULBP1 (which is also GPI-anchored) levels did not
change. This can be explained by preferential loading of different
pro-proteins into the remaining GPIT complexes if the predicted
role of PIGT as the ‘‘gatekeeper’’ (Eisenhaber et al., 2003) of
GPIT is correct. Moreover, even the affected proteins did not
completely disappear from the cell surface. Indeed, partial
activity of the GPIT can be expected because it was reported
previously that a complete lack of PIGT is required for complete
blocking of GPI anchoring (Krawitz et al., 2013), and hypomor-
phic activity of PIGT resulting in partial loss of GPI-anchored
protein presentation has been observed (Kvarnung et al.,
Figure 3. HSV1 miR H8 Inhibits NK Killing
(A) HSV1 miR H8- and control miRNA-expressing BJAB cells labeled with
35S methionine were co-cultured for 5 hr with the NK cell line YTS-ECO at the
effector-to-target (E:T) ratios indicated.
(B) Primary bulk NK cells were incubated for 5 hr with BJAB cells expressing
miR H8, a control miR, shPIGT, or a control shScramble labeled using
35S methionine as above.
(C) BJAB cells expressing miR H8 were co-transduced to overexpress exog-
enous PIGT (PIGT OE) or an empty vector (ds-empty). These cells and control
miR-expressing cells were used in NK killing assays as in (B).
Representative experiments were repeated twice for (A) and (C) and four times
for (B). Target killing is displayed as a percentage of the total. Shown are mean
values ± SEM. *p > 0.05, **p > 0.01, ***p > 0.005.2013). Thus, our results that demonstrate a decrease in PIGT
levels of approximately 40% are consistent with previous
findings.
Recent research characterized the expression dynamics of
HSV1 miRNAs (Du et al., 2015), and miR H8 was found to be ex-
pressed exclusively during reactivation from latency. This finding
is important when taken in conjunction with the results presented
here because the role of miR H8 is somewhat clarified. The func-
tion of immune cells, particularly CD8+ T cells, inmaintaining virallatency and inhibiting HSV1 reactivation has been well estab-
lished, and the role of NK cells in controlling HSV1 infection is
also well documented (Egan et al., 2013; Moraru et al., 2012).
Additionally, duringHSV1 reactivation, the infected cells undergo
various stresses stemming from the de novo expression of viral
transcripts and proteins. Taken together, these findings point to
the importanceof immuneevasionduring earlyHSV1 reactivation
before the main viral protein-based mechanisms are fully active.
For this, utilization of viral miRNAs is ideal because miRNAs are
considered non-immunogenic (Boss and Renne, 2011).
We do not know why miR H8 is expressed only during reacti-
vation; its effects could be utilized by the virus to subvert tetherin
during lytic infection as well. One possible explanation could be
that, during reactivation, HSV1 needs to replicate and egress
from a few selected neurons to establish widespread infection,
and the effects miR H8 might help the virus overcome this initial
limitation. On the other hand, during most of the lytic infection,
a much larger mass of cells is infected, and thus a much higher
viral load is enabled simply by virtue of infected cell mass.
The abovementioned reactivation exclusivity of miR H8
expression presents a distinct problem: all experiments that
aim to ascertain the effect of miR H8 in a bona fide infection
will require a setting in which HSV1 is reactivated. To date, how-
ever, all existing experimental models of HSV1 reactivation
involve research animals (Du et al., 2015; Ramakrishna et al.,
2015; Yao et al., 2014; Kobayashi et al., 2012; Kim et al.,
2014a; Roehm et al., 2011), and because miR H8 targets the hu-
man PIGT transcript exclusively (Figures S2 and S3), performing
such experiments in animals would be non-informative. Thus, an
HSV1 latency reactivation model in human cells is needed in
combination with specific miR H8 knockout (KO) viruses or an
anti-miR H8 antagomiR to determine the physiological impor-
tance of our findings. Importantly, however, the expression
levels of miR H8 in our system were comparable with the levels
observed during reactivation in mouse ganglions (Figure 1C in
this paper and Figure 3 by Du et al., 2015), whenmeasured using
the same qRT-PCR TAQMAN probes. Thus, even though we
did not demonstrate the importance of miR H8 in a bona fide
HSV1 reactivation setting, our experiments using the ectopic
expression of miR H8 closely resemble the settings observed
during HSV1 reactivation.
In conclusion, in this paper we discover that HSV1 miR H8 tar-
gets PIGT of the GPI anchoring pathway, enabling HSV1 to
vitiate the host immune response, inhibiting elimination by NK
cells and curbing the cell-intrinsic capacity to limit viral
spreading. Thus, by using a single microRNA to target a basic
cellular pathway, HSV1 is able to subvert the host immune
response at several key points. The importance of understanding
HSV1 biology and life cycle has recently been reiterated as its
possible roles in Alzheimer’s disease (Itzhaki, 2014) and even
cancer (Yun et al., 2015) are being discovered and investigated.EXPERIMENTAL PROCEDURES
Cell Culture, Lentiviral Constructs, Production, and Transduction
Cells were kept in their common corresponding media. RNA artificial hairpins
(Table S1), orthologs of pre-miRNA, were generated and cloned into lentiviral
vectors. Lentiviruses were generated in 293T cells and used to transduceCell Reports 17, 949–956, October 18, 2016 953
Figure 4. HSV1 miR H8 Expression Reduces
Tetherin Surface Presentation, Enhancing
Viral Spread
(A, C, and D) BJAB cells expressing miR H8 (A),
pre-miR H8 (C), or shPIGT (D) stained for tetherin
(black histograms). Empty gray histograms re-
present control miRNA-expressing (A and C) or
scramble shRNA-expressing (C) cells. The full gray
histogram represents staining with secondary
antibody only.
(B) Fold change in tetherin staining MFI (as in A) of
miR H8 compared with control miRNA-expressing
cells, calculated and analyzed using a single
sample t test (n = 6).
(E) HSV1 viral titers calculated in Vero cells
incubated with supernatants from BJAB cells
expressing HSV1 miR H8, a control miRNA,
shScramble, shPIGT, or shTetherin and infected
with HSV1 for 72 hr (n = 2).
(F) HSV1 viral titers calculated in Vero cells
incubated with supernatants from BJAB
cells expressing HSV1 miR H8 concomi-
tantly with exogenous PIGT/empty vector
(H8-PIGT/H8-ds) and infected with HSV1.
BJAB cells expressing a control miRNA and
empty vector (control miR-ds) were used as
a negative control, whereas BJABs express-
ing shTetherin were used as a positive one
(shTet).
(G) Relative HSV1 release calculated as a pro-
portion of total viral titers (supernatant and cell-
associated). The abbreviations are the same as in
(E) and (F).
(H) A549 cells overexpressing exogenous
tetherin and HSV1 miR H8 or an empty control
vector were infected with HSV1 for 72 hr. Super-
natants were then used to calculate viral titers in
Vero cells.
All error bars represent SEM. For (A), (C), and (D),
n = 6. For (E)–(H), n = 2. *p > 0.05, **p > 0.01,
***p > 0.005.target cells. Transduction efficiency was assessed by GFP, and only cell
populations with >90% efficiency were used for experiments. A detailed
description of the primers and procedures used for cell culture and cloning
is included in the Supplemental Experimental Procedures.
Cytotoxicity Assays and NK Cell Preparation
The cytotoxic activity of NK cells against various targets was assessed in 5-hr
35S release assays as described previously (Mandelboim et al., 1996). NK cells
were isolated from peripheral blood using the human NK cell isolation kit and
the Cell-Sep kit (STEMCELL Technologies) according to themanufacturer’s in-
structions. The NK purity was close to 100% as determined by FACS analysis.
Viral Titer Experiments
2 3 105 BJAB cells expressing miR H8 or an empty Sin-GFP vector were
infected with HSV-1 OK14 at a multiplicity of infection (MOI) of 0.2 for 72 hr.
Supernatants were collected and used to infect Vero cells, and, 48 hours
post infection (hpi), viral plaques were counted. For relative viral release as-
says, cells were infected with HSV1 as above for 24 hr. The cell pellet was
then frozen and thawed three times to release viral progeny, and the superna-
tant and cell pellet fractions were used for titration in Vero cells as above. HSV1
release proportions = supernatant virus/(supernatant virus + cell-associated
virus). The HSV-1 OK14 was a gift from Oren Kobiler and generated by954 Cell Reports 17, 949–956, October 18, 2016cotransfecting BamHI-digested pHSV1(17+)Lox-mRFPVP26 and purified
HSV-1(17+) DNA (O. Kobiler and L.W. Enquist, personal communication).
The pHSV1(17+)Lox-mRFPVP26 was a kind gift from Drs. Katinka Do¨hner
and Beate Sodeik (Nagel et al., 2012, 2014).
Flow Cytometry
For flow cytometry, cells were incubated overnight at equal densities. Cells
were incubated on ice for 1 hr with the primary antibody at a concentration
of 0.2 mg/well. Appropriate secondary antibodies were applied for 30 min on
ice at a concentration of 0.75 mg/well. Unless otherwise noted, cells expressing
HSV1 miR-H15 were used as a control for the miR H8-expressing cells. For a
detailed account and a list of antibodies used, see the Supplemental Experi-
mental Procedures.
qRT-PCR
Details of the qRT-PCR procedure and a list of primers are included in the
Supplemental Experimental Procedures and Table S2.
Luciferase Assay
The generation of the firefly luciferase constructs was as described previously
(Stern-Ginossar et al., 2007). For more details, please consult the Supple-
mental Experimental Procedures and Table S3.
Statistical Methods
For statistical significance, Student’s t test analysis was used. A statistical test
was considered significant when p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.09.077.
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